Alphabet Ramps Up AI Spending to $175-185 Billion in 2026
Alphabet (GOOGL) announces massive $175-185B capital expenditure for 2026, far exceeding analyst expectations of $115B, as Google deepens AI investments amid growing competition.
NOTRELOAD AI
Arm Shares Rebound as AI and Data-Center Growth Boost Investor Confidence
Arm stock rises after analysts praise earnings, highlighting AI-driven data-center growth despite smartphone market concerns.
MGM Resorts Posts Strong Q4 Growth Driven by Casino Revenue
MGM Resorts expects Q4 profit to more than double to $293.6M, beating analyst estimates, while BetMGM swings to profitability with strong online gaming growth.
Amgen Beats Q4 Expectations Despite FDA Drug Controversy
Amgen (AMGN) reports strong Q4 2025 earnings with $9.87B revenue, beating estimates. Company defies FDA request to withdraw Tavneos while advancing obesity drug MariTide through trials.
IonQ Under Fire: Pentagon Contracts May Not Be What They Seem
Short-seller report claims quantum computing company IonQ lost vital Pentagon funding that made up 86% of revenue, acquired non-quantum businesses to hide losses, and insiders sold $397M in stock.
Cumberland Pharma Gets FDA Fast Track for Groundbreaking DMD Heart Treatment
Cumberland Pharmaceuticals receives FDA Fast Track designation for ifetroban, a promising new oral therapy targeting fatal heart disease in Duchenne muscular dystrophy patients.